SeraGene Therapeutics is a privately held biotechnology company based in Vancouver, Canada that specializes in the development of long-lasting RNA-based therapies for treating blood coagulation disorders (bleeding, thrombosis, and inflammation).
With extensive expertise in nanomedicine and clotting biology, we hope to one day realize a future where patients with coagulation disorders no longer live in fear of their next bleed or clot
Company Details
- Employees
- 8
- Founded
- -
- Address
- 2405 Wesbrook Mall, Vancouver,british Columbia,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.seragenetx.com/
- Keywords
- Nanomedicine, Bleeding, Thrombosis, RNA, Gene Therapy, Womens Health, Platelet Dysfunction.
- HQ
- Vancouver, British Columbia
Seragene Therapeutics Questions
Seragene Therapeutics's website is https://www.seragenetx.com/
Seragene Therapeutics's LinkedIn profile is https://ca.linkedin.com/company/seragene-tx
Seragene Therapeutics has
8 employees.
View email and phone details for 8
employees at Seragene Therapeutics.
Seragene Therapeutics's industry is
Biotechnology Research
Seragene Therapeutics's top competitors are
Ability Biotherapeutics,
Neuropeutics Inc,
Cerecura Nanotherapeutics,
Hdax Therapeutics,
Simmunome Inc.,
9bio Therapeutics,
Mesentech,
Neiges Biotechnologies,
Kapoose Creek Bio,
Reverb Therapeutics.
Seragene Therapeutics's categories are Biotechnology Research
Seragene Therapeutics's founding year is 2022
